MENU
VTYX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ventyx Biosciences (VTYX) Earnings Date & Reports

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders... Show more

A.I. Advisor
published Earnings

VTYX is expected to report earnings to rise 41.03% to -45 cents per share on March 19

Ventyx Biosciences VTYX Stock Earnings Reports
Q4'25
Est.
$-0.45
Q3'25
Beat
by $0.13
Q2'25
Beat
by $0.08
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.13
The last earnings report on November 07 showed earnings per share of -31 cents, beating the estimate of -44 cents. With 1.40M shares outstanding, the current market capitalization sits at 678.62M.
View a ticker or compare two or three
VTYX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VTYX showed earnings on November 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12790 El Camino Real
Phone
+1 760 593-4832
Employees
80
Web
https://www.ventyxbio.com